Breaking through the treatment desert of conventional mesothelin-targeted CAR-T cell therapy for malignant mesothelioma: A glimpse into the future
Saved in:
Main Authors: | Yuning Wang (Author), Guo Zhao (Author), Shujun Xing (Author), Shuhang Wang (Author), Ning Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
by: Laura Castelletti, et al.
Published: (2021) -
Commentary on "Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects"
by: Yuning Wang, et al.
Published: (2024) -
A Glimpse in the Future of Malignant Mesothelioma Treatment
by: Gaetano Pezzicoli, et al.
Published: (2021) -
Neoantigen-based therapeutic cancer vaccine: Towards a bright future
by: Yuning Wang, et al.
Published: (2024) -
Mesothelin versus Ca125 in Screening the Ovarian Malignancy
by: Meliana Jayasaputra, et al.
Published: (2016)